Results 111 to 120 of about 27,706 (210)

Microbial transformation of artemether.

, 2013
Microbial transformation of artemether.
Liwang Cui (82978), Zhen Cao (30837), Wei Zhang (405), Guiyu Tan (484227), Yongliang Cui (484225), Rui Zhang (13940), Suqin Guo (484224), Lishan He (484226), Liang Zhang (41392), Baomin Wang (174006)   +9 more
core   +1 more source

The effects of artemether, shRNA-VCAM-1 and artemether combined with shRNA-VCAM-1 on the expression of p-Akt.

, 2013
(A) U87 cells were treated with artemether (300 µmol/L) and shRNA-VCAM-1 alone or in combination. (B) Statistical analysis. The expression of p-Akt was checked with Western Blot. p-Akt was significantly inhibited in artemether and artemether+shRNA-VCAM-1
Yi Hu (58993), Yi-Xue Xue (321473), Ying-Bin Wang (101805), Yun-Hui Liu (401748), Ping Wang (42415), Yi-Long Yao (401747), Bo Yu (241082), Zhen Li (49109)   +7 more
core   +1 more source

Antimalarial Drug Repurposing of Epirubicin and Pelitinib in Combination with Artemether and Lumefantrine

Pharmaceuticals
Background: Drug therapy remains the principal management strategy for malaria but is increasingly challenged by the emergence of drug-resistant malaria parasites.
Douglas O. Ochora, Reagan M. Mogire, Bernard M. Murithi, Farid Abdi, Erick N. Ondari, Rael J. Masai, Edwin Mwakio, Agnes Cheruyiot, Abiy Yenesew, Hoseah M. Akala   +9 more
doaj   +1 more source

Artemether-lumefantrine for treating uncomplicated falciparum malaria.

, 2003
BACKGROUND: Artemether-lumefantrine is being promoted by the World Health Organization for treating uncomplicated malaria. It is expensive. We sought evidence of its superiority over existing treatment regimens.
Omari, A. A., Gamble, Carrol, Garner, P.; id_orcid   +2 more
core   +1 more source

Artemether in cerebral malaria

The Lancet, 1993
Taylor, T, Wills, B, Wirima, J, Molyneux, M   +3 more
openaire   +2 more sources

Meningeal inflammation increases cerebrospinal fluid artemether concentrations in Papua New Guinean children treated with intramuscular artemether

, 2011
Although the artemisinin-associated neurotoxicity identified in vitro and in animal studies has not been confirmed clinically, only one adult study has measured cerebrospinal fluid (CSF) concentrations after administration of conventional doses ...
T. Davis (7795394), I. Mueller (18998843), L. Manning (23342176), I. Hwaiwhanje (23552089), P. Siba (23308414), M. Laman (23323696), N. Morep (23552092), H. Karunajeewa (23338708), S. Salman (18165823), Madhu Page-Sharp (563874)   +9 more
core  

Formulation and Optimization of Artemether-Loaded Nanoemulsions by Applying QbD. [PDF]

Pharmaceuticals (Basel)
Alhamhoom Y, Hani U, Bobbarjang N, Rashid MA, Eranti B, Venkatesh B, AlQahtani F, Helal HA, Vaggu M, Sai MK.   +9 more
europepmc   +1 more source

Research Progress on Anti-Inflammatory and Antioxidant Mechanism of Artemether Based on MAPK/NF-κB Signaling Pathway. [PDF]

Int J Mol Sci
Yang M, Feng K, Li Y, Zeng S, Ma H, Feng H.   +5 more
europepmc   +1 more source

Improved protocols using sodium artesunate for the treatment of experimental cerebral malaria. [PDF]

Antimicrob Agents Chemother
Merlone MP, Gomes F, Sanches GS, Daniel-Ribeiro CT, Carvalho LJdM.   +4 more
europepmc   +1 more source

Resolving human α versus β cell fate allocation for the generation of stem cell-derived islets. [PDF]

Nat Commun
Akgün Canan M, Cozzitorto C, Sterr M, Saber L, Setyono ESA, Dema A, Kozawa K, Wang X, Merl-Pham J, Greisle T, Burtscher I, Lickert H.   +11 more
europepmc   +1 more source